Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | VP, General Counsel & Corp Sec | January 08, 2025 | January 10, 2025 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | SVP, Gen. Counsel & Secretary | May 31, 2022 | June 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date January 08, 2025 · Filed January 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,506 |
Ending reported balance
After 2025-01-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-01-08 · Exercise / conversion · Acquired 1,140 · Balance 2,017 Row 2 · 2025-01-08 · Exercise / conversion · Acquired 2,352 · Balance 4,369 Row 3 · 2025-01-08 · Tax withholding · Disposed 579 · Balance 3,790 Row 4 · 2025-01-08 · Tax withholding · Disposed 1,284 · Balance 2,506 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-12-13 | Direct | 2,272 |
Reported balance
After 2025-01-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-01-08 · Exercise / conversion · Disposed 1,140 · Balance 2,272 F1: This award vests 25%/year over 4 years - 1,136 shares on 1/8/2024, 1,140 shares on 1/8/2025, 1,136 shares on 1/8/2026, 1,136 shares on 1/8/2027 - subject to continued service. F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-12-12 | Direct | 7,052 |
Reported balance
After 2025-01-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-01-08 · Exercise / conversion · Disposed 2,352 · Balance 7,052 F3: This award vests 25%/year over 4 years - 2,352 shares on 1/8/2025, 2,352 shares on 1/8/2026, 2,348 shares on 1/8/2027, 2,352 shares on 1/8/2028 - subject to continued service. F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This award vests 25%/year over 4 years - 1,136 shares on 1/8/2024, 1,140 shares on 1/8/2025, 1,136 shares on 1/8/2026, 1,136 shares on 1/8/2027 - subject to continued service.
F2: Adjusted to reflect Issuer's 4-for-1 stock split effected on 2/16/2024.
F3: This award vests 25%/year over 4 years - 2,352 shares on 1/8/2025, 2,352 shares on 1/8/2026, 2,348 shares on 1/8/2027, 2,352 shares on 1/8/2028 - subject to continued service.
STANDARD BIOTOOLS INC.
Report date May 31, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,480 |
Reported balance
After 2022-05-31 transaction · row 1
1 source rowRow 1 · 2022-05-31 · Grant · Acquired 3,341 · Balance 100,480 F1: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2018 Filed May 23, 2018 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000061 · wf-form4_152703725342427.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000061 · wf-form4_152703725342427.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 22, 2018 01:03 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $6.33 | $0.00 |
DisclosureSEC source: 0001162194-18-000038 · wf-form4_152168056299965.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2028-03-19 F1 · derivative.exercise_date: 12/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000028 · wf-form4_151933520414381.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,042 Underlying: Common Stock · 1,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000028 · wf-form4_151933520414381.xml · derivative · entry 4 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,082 | $7.81 | $8,450.42 |
DisclosureSEC source: 0001162194-18-000028 · wf-form4_151933520414381.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,328 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000028 · wf-form4_151933520414381.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000028 · wf-form4_151933520414381.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 378 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000166 · wf-form4_151140242318737.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,017 Underlying: Common Stock · 1,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000166 · wf-form4_151140242318737.xml · derivative · entry 4 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 997 | $5.19 | $5,174.43 |
DisclosureSEC source: 0001162194-17-000166 · wf-form4_151140242318737.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000166 · wf-form4_151140242318737.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 675 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000166 · wf-form4_151140242318737.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,643 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000147 · wf-form4_150612946488249.xml · derivative · entry 4 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,643 Underlying: Common Stock · 56,643 shares Expires not disclosed F5 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 79,300 shares of FLDM common stock granted to the Reporting Person on February 13, 2017. In exchange, the Reporting Person received a replacement Option, for 56,643 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 79,300 | Not disclosed Strike: $6.16 | Not disclosed |
DisclosureSEC source: 0001162194-17-000147 · wf-form4_150612946488249.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79,300 shares Expires 2027-02-13 F5 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 79,300 shares of FLDM common stock granted to the Reporting Person on February 13, 2017. In exchange, the Reporting Person received a replacement Option, for 56,643 shares, having an exercise price of $5.13 per share. F4 · derivative.exercise_date: The Option provided for vesting in forty-eight equal monthly installments beginning on February 1, 2017. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 13,500 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000147 · wf-form4_150612946488249.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2027-09-20 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 27,000 shares of FLDM common stock granted to the Reporting Person on August 9, 2016. In exchange, the Reporting Person received a replacement Option, for 13,500 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 27,000 | Not disclosed Strike: $9.05 | Not disclosed |
DisclosureSEC source: 0001162194-17-000147 · wf-form4_150612946488249.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires 2026-08-09 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 27,000 shares of FLDM common stock granted to the Reporting Person on August 9, 2016. In exchange, the Reporting Person received a replacement Option, for 13,500 shares, having an exercise price of $5.13 per share. F1 · derivative.exercise_date: The Option provided for vesting of 12/48th of the total number of shares subject to the Option on June 20, 2017 and thirty-six equal monthly installments beginning on July 20, 2017. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000118 · wf-form4_150352233665919.xml · derivative · entry 5 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,992 Underlying: Common Stock · 1,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000118 · wf-form4_150352233665919.xml · derivative · entry 4 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 3,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On August 9, 2016, the Reporting Person was granted 10,800 Restricted Stock Units of which 14/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,927 | $3.60 | $6,937.20 |
DisclosureSEC source: 0001162194-17-000118 · wf-form4_150352233665919.xml · nonDerivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,729 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000118 · wf-form4_150352233665919.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000118 · wf-form4_150352233665919.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000055 · wf-form4_149558010045316.xml · derivative · entry 3 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,967 Underlying: Common Stock · 2,633 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,102 | $5.46 | $6,016.92 |
DisclosureSEC source: 0001162194-17-000055 · wf-form4_149558010045316.xml · nonDerivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,531 Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000055 · wf-form4_149558010045316.xml · nonDerivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:11 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 79,300 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001162194-17-000006 · wf-form4_148719667212712.xml · derivative · entry 2 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,300 Underlying: Common Stock · 79,300 shares Expires 2027-02-13 F3 · derivative.exercise_date: 1/48th of the total number of shares subject to the option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option will be fully vested on January 1, 2021, subject to recipient continuing to be a Service Provider (as defined in the Fluidigm Corporation 2011 Equity Incentive Plan) through each such date. "Vesting Commencement Date" shall mean January 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:11 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 31,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000006 · wf-form4_148719667212712.xml · derivative · entry 1 Khadder Nicholas · CIK 0001598911 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,600 Underlying: Common Stock · 31,600 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.